Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 158 results for "lupin ltd"

Lupin Ltd in Consumer Health (South Africa)

1 of 3 Lupin Ltd aims to pursue growth through further accelerating its progress and expanding its presence in select geographic regions. The company has already embarked on some key initiatives that should drive the future growth of the ... Research and Markets, 2 days ago
Lupin dips on disappointing Q2 results Smart Investor, 1 month ago
Reuters India

Pharma M&A is an absolute seller's market: Alpesh Dalal of Lupin

Lupin Ltd, India's second largest drugmaker by market value, had been pursuing inorganic expansion during 2007-11, but had gone quiet on the mergers and acquisitions (M&A) front since then. Early last year, it revived its M&A-led growth strategy... ...
 VC Circle1 week ago Lupin profit below estimates  Reuters India1 month ago India's Lupin Q2 profit lags estimates on fewer drug launches  Reuters India1 month ago India's Lupin sees more US drug approvals after disappointing results  Yahoo! Finance1 month ago

Talwalkars buys 51% in Chennai's Inshape Health

Lupin Ltd. is a pharmaceutical company and is engaged in formulation of drugs and active pharmaceutical ingredients (APIs), generics, biotechnology, novel drug discovery and development, drug delivery systems and specialty pharmaceuticals. The firm ...
 VC Circle1 week ago The '1 trillion FDA impact on Indian pharma industry  HT Syndication1 week ago Sun Pharma starts tender offer for InSite Vision buyout  Livemint.com2 months ago The Rs1 trillion FDA impact on Indian pharma  Livemint.com1 week ago

The secret of Rakesh Jhunjhunwala's success

An analysis of Rakesh Jhunjhunwala's portfolio shows that his average returns have been highest from the stocks he held the longest At a time when high-frequency trading has allowed stock market participants to transact in milliseconds, India's ...
 Livemint.com1 week ago
Hindustan Times

Is India facing unfair diplomatic assault on FDI?

In a world where globalisation has replaced colonial exploitation and Cold War tensions, one would expect trade and business to make a more peaceful world. But tensions persist and it is time to ask: Is India being unfairly pummeled on investor ...
 Hindustan Times1 week ago

Japan's growing generic market woos more pharma firms

Health & Lifestyle MintAsia Magazines Mumbai, Nov. 20 -- Four years after the last buyout, more Indian pharmaceutical firms are eyeing acquisition opportunities in Japan, the world's second largest drug market. Except Mumbai-based Lupin Ltd, which ...
 HT Syndication1 week ago

Indian Firms Foreign Investments Drop 21% to $2.28 Billion

0035 Economy/ International Mumbai, November 18 (QNA) Foreign direct investments by Indian firms dropped 21% to US $2.28 billion in October 2015 compared to the same month last year, according to Reserve Bank of India (RBI) data today. Indian ...
 Federation of Arab News Agencies1 week ago
Financial Express

India Inc's overseas direct investment slides 21%

18 November 2015, Mumbai, PTI Direct investments by Indian firms abroad fell 21 per cent to $2.28 billion in October 2015 compared to the same month last year, according to RBI data. Indian companies had put in $2.88 billion in the form ...
 Millennium Post1 week ago India Inc's overseas invt down 21 pc at $2.28 bn in Oct  New Delhi Pioneer1 week ago India Inc's overseas investment down 21% at $2.3bn in October  MyInforms1 week ago India Inc Oct overseas investment falls to $2.3 b  Hindu Business Line1 week ago

Court Report - November 2015 #4

About Court Report: Each week we will report briefly on recently filed biotech and pharma cases . Vivus, Inc. v. Actavis Laboratories FL, Inc. 2:15-cv-06256; filed August 17, 2015 in the District Court of New Jersey • Plaintiff: Vivus, Inc.
 JD Supra1 week ago
DNA India

Lupin Q2 Net Down 35% On Slow US Sale

ByCH Unnikrishnan Drug maker Lupin Ltd on Tuesday (October 27) posted 35 per cent drop in net profit at Rs 408 crore during the July-September quarter as against Rs 630 crore a year ago. Its sales during the quarter at Rs 3178 crore grew just 2 ...
 Businessworld India1 month ago Slowdown in product approvals bring Lupin Q2 net down 35%  DNA India1 month ago Lupin Q2 net dips 35 per cent to Rs 409 crore  Economic Times1 month ago Lupin Q2 net dips 35% to Rs 409 crore  Times of India1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less